ABSTRACT Objective ： To investigate the prevention effect of aqueous extract of Epimedii sagi ttatum （ESE） on ovariectomyinduced （OVX） bone loss in rats ． Methods ：Rats were divided into shamoperated and OVX groups ． The OVX rats were divided into four groups treated with distilled water ， 17βestradiol （1 mg／kg ， ig） and ESE （0 ．5 and 1 g ／kg ， ig） for 11 weeks ． Serum calcium ， phosphorus ， estradiol ， bone gla protein concentrations and serum alkaline phosphatase activi ty were measured ． Bone density was assayed by dualenergy Xray absorptiometry ． The undecalcified longitudinal proximal tibial metaphysical sections were cut and stained for the bone histomorphometric analysis ． Results ： In OVX rats ， alkaline phosphatase activity in serum was markedly increased by ESE treatment ， which had no obvious influence on the body weight ． Meanwhile ， atrophy of uterus and descent of bone mineral density were suppressed by ESE treatment ． In addition ， ESE completely corrected the decreased concentrations of calcium and E2 in serum observed in OVX rats ． Histological resul ts also showed ESE prevented the increases in trabecular separation （Tb ． Sp） in OVX rats whereas it did not alter trabecular thickness （Tb ．Th） and trabecular number （Tb ．N） in OVX rats ． Moreover ， ESE had remarkable effect on bone format ion rate with bone volume as referent （BFR／ BV） and bone formation rate with bone surface as referent （BFR／BS） ． Conclusion ：The findings assessed on the basis of biochemical test ， bone mineral density and histomorphometric parameters show that aqueous extract of Epimedii sagittatum has a definite antiosteoporotic effect and can prevent the OVXinduced bone loss in rats
Osteoporosis is a chronic ， progressive disease of the skeleton characterized by bone fragility due to a reduction in bone mass and possibly alteration in bone architecture which leads to a propensity to fracture with minimum trauma ［ １ ］ ． Many synthetic agents such as estrogens in hormone replacement therapy ， selective estrogen receptor modulators like raloxifen ， droloxifen ， bisphosphonates and cal citonin have been developed to treat osteoporosis but each one of them is associated with side effects such as hypercalcemia ， hypercalciurea ， increased risk of endometrial and breast cancer ， breast ten derness ， menstruation ， thromboembolic events ， vaginal bleeding and hot flushes ［ ２ ， ３ ］ ． So active attempts still are being vigorously pursued to find novel inhibitors of bone resorption that minimize bone loss in postmenopausal women ， thus decrea sing the necessity for drug therapy ． The Herba Epimedii （ Berberidaceae family） is a famous Chinese herbal medicine ， made from the dried aerial parts of Epimedium brevicorn um Maxim ．， Epimedium sagit tat um （ Sieb ． et Zucc ．） Maxim ．， Epimedium pubescens Maxim ， Epimedium wushanense T ．S ． Ying ． and Epime dium koreanum Nakai ［ ４ ］ ． They have commonly been used in the treatment of cardiovascular disea ses and other chronic illnesses （bronchitis ，infertil ity ， amnesia and asthenia ， impotence and senile functional diseases ） in China for over ２ ０００ years ［ ５ ］ ． Herba Epimedii is a typical "kidneytoni fying" traditional Chinese medicine ． According to traditional Chinese medicine theory ， " kidney" con trols bone ． The " kidneytonifying" action of tradi tional Chinese medicine might have relationship with bone formation ． Currently ， Herba Epimedii is applied in many Chinese formulas for antiosteo porosis ［ ６ ］ ．Pharmacological studies also showed that it had potential function against osteoporosis ［ ７ ， ８ ］ ． In China ， it has also been used to improve and tonify the Yang ． However ， it is not clear whether Herba Epimedii affects bone formation and what the mechanism is for antiosteoporosis ． T he pur pose of this study is to evaluate whether the extract of Epimedii sagittat um （ ESE ） is effective in ameliorating bone loss due to ovariectomy （OVX） and ，if so ，whether it functions in a manner similar to estrogen ．
MATERIALS AND METHODS

．1 Materials and reagents
Aerial parts of Epimedii sagittatum （ Sieb ．et Zucc ．） （including branches and leaves） were col lected in a valley ， located in Bozhou ， Anhui Prov ince ，China ，in September ２００４ ． The raw material was identified by Hanchen Zheng ， a professor of pharmacognosy in the Second Military Medical University ， China ． A reference specimen （ voucher No ． ２００４０９０３） has been deposited in the Herbari um of the Second Military Medical University ，Chi na ． １７βestr adiol w as purchased fr o m Sha ng hai H ualia n P ha r mace utical Co ． L t d ． T he reage nt kits f or m easure men t of calciu m ， ino r ga nic p hosp ho rus and alkaline phosphatase activit y in seru m w er e o b tained f r om Fo r tu ne Biome dical Engineering Co ． L t d ． （ Shang hai ， China ） ． Ra dioim m unoassay （RI A） kits f or measure ment o f estr adiol a nd bone gla pro tein （ BG P ） level s w er e pur chased fr o m A to mic Ener gy Instit u te of China ． Goldner＇s stai ning reag ents w ere purchased fr o m S ig m a Chemical C o ． L td ． M ethy l met hacr ylate ， dibut yl pht halate ， benzo yl per o xide and ot her reage nts w e re do mestic analy tical g r ade ． 2 ．2 Preparation of extract T hree liters of water were added to ０ ．３ kg fresh whole plant of E ． sagittatum （ Sieb ．et Zucc ．） ， and were decocted for ４ h ． After filtration ， the aqueous extracts were concentrated in ０ ．２ g （crude drug）／ml under reduced pressure at ５０ ℃ ， and stored at -２０ ℃ until use ． The extract yield was about ３ ％ ． The extracts （ESE） diluted to ０ ．１ g （crude drug）／ml in water were administrated orally to rats at a volume of １０ ml／kg body weight ．To the control rats ， water was administered in a similar way ． 2 ．3 Animals Fifty female SpragueDawley rats ， １２ weeks of age ， were purchased from SLAC Laboratory Animal Co ． Ltd ，Shanghai ，China ，and acclimated to condi tions for one week before the experiment ． To de velop bone loss in ovariectomized rats ， the exper i mental animals were housed in an airconditioned room at （ ２３ ± ２ ） ℃ with １２ h／１２ h lightdark
illumination cycles at constant temperature （ ２４ ± ０ ．５） ℃ and humidity （ ４５ ％ ５０ ％ ） ． Food and drinking water were supplied ad libit um ． At the beginning of the study they were ３ months of age with an average weight of ２００ g ． The rats were weighed every week during the experiments ． All animal experiments were performed according to the ethical guidelines suggested by the Institutional Animal Ethics Committee and Committee for the Pur pose of Control and Supervision of Experiments on Ani mals ， Ministry of Health ，and Government of China ． 2 ．4 Ovariectomy and administration of Ep ime dii extract
The rats were randomly divided into five groups （ n ＝ １０） ． Four groups were OVX groups and one group was shamoperated group ． Rats in the four OVX groups were treated with vehicle （ water ） ， １７βestradiol （１ mg／kg ， once every week ， ig） ［ ９ ］ or ESE （０ ．５ ，１ g／kg ，daily ， ig） for １１ weeks ，respec tively ． Rats in the shamoperated group were treated orally with vehicle ．１７βestradiol tablet was dissolved and adjusted with physiological saline for an appropriate concentration ． Surgery of animals was done under pentobarbital sodium （ ５０ mg／kg ， i ． p ．） anesthesia ． Bilateral ovariectomies were performed from a dorsal ap proach with a small midline dorsal skin incision ． The shamoperated rats were subject to sham sur gery exposing ， but the ovaries were not removed ． Success of ovariectomy was confirmed at necropsy by failure to detect ovarian tissue and by observa tion of marked atrophy of uterine horns ． At the end of the treatment ， blood samples from rats of all the groups were withdrawn by tail vein method to assess biochemical parameters ． T he ani mals were then sacrificed by using ether anesthesia and the femora ， tibia ， and lumbar vertebra were dissected and stored in a freezer at -８０ ℃ until examination for biomechanical testing and to study histopathological changes ． Several organs ， inclu ding the uterus ，vagina and pituitary were dissected out ，and immediately weighed ［ １ ０ ］ ． 2 ．5 Evaluation of parameters 2 ．5 ．1 Biochemical parameters Serum calcium （ Ca） and inorganic phosphorus （Pi） concentrations ， and serum alkaline phospha tase （ALP） activity were measured on an automatic analyzer （CibaCorning ５５０ ， USA） by using Beck man's diagnostic reagent kit for the in vitro deter mination ． The levels of estradiol （E２ ） and bone gla protein （BGP） were determined by using a specific and sensitive doubleantibody RIA kit on a γray
The femurs were cleaned of adhering soft tissues and the total length and width （ midshaft ） were measured with digital calipers ． The bone mineral density （BMD ， g／cm ２ ） of the left femur was meas ured by dualenergy Xray absorptiometry （ LUNAR Co ． Ltd ．， USA） by using the small animal scan mode ［ １ ２ ］ ． 2 ．5 ．3 Histomorphometric analysis
The left proximal tibia metaphyses were opened to expose the marrow cavity by using an isomet low speed saw （ Buechler LTD ， USA） and fixed in １０ ％ phosphate buffer formalin for ２４ h ． They were then dehydrated in ethanol ， defatted in xylene and em bedded undecalcified in methyl methacrylate ． The frontal sections were cut at ４μm and １０μm thick ness with microtome （ L eica RM ２１５５ ， Germany） ． The ４μm sections were stained with Goldner ' s Trichrome staining for static histomorphometric measurements ， and the unstained １０μm sections were used for dynamic histomorphometric analyses ． Static measurements included the percentage of tra becular area （ ％ Tb ． Ar ） ， trabecular thickness （Tb ．Th） ， trabecular number （ Tb ．N） and trabecu lar separation （ Tb ．Sp ） ． Dynamic measurements included the percentage of labeled perimeter （ ％ L ．Pm） ， mineral apposition rate （ MAR ） ， bone formation rate with tissue volume as referent （BFR／ TV） ， bone formation rate with bone volume as referent （BFR／BV） and bone formation rate with bone surface as referent （BFR／BS） ． 2 ．6 Statistical analysis The data were analyzed by using one way analysis of variance （ANOVA） followed by post hoc Sheffe＇s Test using SPSS computer software Version ７ ．０ ． Level of significance was fixed at ０ ．０５ ．
RESULTS
．1 Body weight
The body weight of OVX rats was significantly higher than that of the shamoperated rats （ Figure   １） ． After １１ weeks ， the body weights in the sham operated and OVX rats were （２９０ ± １３） g （ mean ± SD ， n ＝ １０ ） and （ ３５８ ± １４） g （ n ＝ １０） ， respec tively （Table １） ．Increase in the body weight of an imals treated with ESE （OVX ＋ ESE） was almost the same as that in OVX ＋ １７βestradiol rats （in １３ ～ １４ weeks） and less than that in OVX rats （Figure １） ． With the administration of １７βestradiol to the OVX rats （OVX ＋ １７βestradiol） ， the increase was almost the same as that in the shamoperated rats ． · ０ ３ ６ · Figure 1 Changes in body weight in rats R at s w er e sh a m -o per at ed （ ■ ） ， ovariect omized （ • ） ， a nd a dminist er ed E S E （１ g ／k g ） （ △ ） and １７βes tr adi ol （ ▲ ） ． T h e c ha n ges i n E S E （０ ．５ g／k g ） gr o up w er e th e sam e as E SE （１ g／k g ） g r oup ， t he cur v e of w h ich w as n ot s h o w n ． Eac h p oi n t re pr ese n ts t he m ea n ± S D （ n ＝ １０） ．  P ＜ ０ ．０５ and   P ＜ ０ ．０１ ， v s ov a riect o mized g r oup at c o rr esp ondi n g t im es ．
．2 Uterine weight
As shown in Table １ ， the uterine weights of the shamoperated and OVX rats differed significantly （ P ＜ ０ ． ０１ ） ． The weight of the OVX ＋ ESE （０ ．５ g／kg）group was higher than that of the OVX group near ly by ６４ ％ ． The difference was statistically significant ． The weight of the １７βestradiol group was similar to that of the sham operated rats ． The weight of the OVX ＋ ESE （０ ．５ g／kg）group was also almost similar to that of the OVX ＋ ESE （１ g／kg） group ． 3 ．3 Bone mineral density As shown in Table １ ， the femur bone mineral densities （ BMD ） of the shamoperated and OVX rats were （０ ．２６３ ± ０ ．０１１） and （０ ．２４８ ± ０ ．００９） ， respectively ． This indicated that the ovariectomy decreased the BMD by ５ ．７ ％ ． The administration of ESE （ １ g／kg ） to the OVX rats significantly recovered the BMD ． The OVX ＋ １７βestradiol rats restored BMD almost completely to the level of the shamoperated rats ， whereas the OVX ＋ ESE （０ ．５ g／kg） group had no effect ． 3 ．4 Serum parameters Results of serum parameters of different groups of animals are in Table ２ ．The results indicate a significant reduction in the serum calcium in OVX rats when compared with the shamoperated ， ESE and １７βestradiol treated animals ． The serum phosphorus was decreased in OVX rats ． １７β estradiol can recover the level and ESE has no such effect ． Statistically significant （ P ＜ ０ ．０５） elevated level of serum A LP was observed in the OVX animals when compared with the shamoperated animals ． Treatment with ESE reduced the serum ALP levels （ P ＜ ０ ．０５） ． Moreover ， ovariectomy induced a decrease in serum E２ ，and treatment with ESE or １７βestradiol improved E２ level compared with the OVX group ． However ， there were no significant differences in the serum BGP levels among any groups except OVX ＋ ESE （ １ g／kg） compared with OVX rats ． 3 ．5 Histomorphometric examination This morphological observation was quantitated by histomorphometric analysis of longitudinal cross sections obtained from the proximal tibiae ． A marked bone loss was observed in the OVX rats when compared with the shamoperated controls （Table ３） ． This bone loss was accompanied with a remarkable decrease in Tb ． N and Tb ． Th ， and increase in Tb ．Sp （ vs shamoperated ， Table ３ ） ． The １７βestradiol could partially prevent the bone loss at the proximal tibia metaphysic （ P TM ） of OVX rats ． In OVX rats treated with ESE ， the ％ Tb ．Ar increased （ P ＜ ０ ．０５ ， vs OVX ， Table ３） ， Tb ．Sp decreased （ P ＜ ０ ．０５ ， vs OVX ， Table ３） ． The dynamic parameters of the bone such as BFR／ BS and BFR／BV were increased in rats treated by ESE （Table ４） ． ESE had no significant influence on parameters such as ％ L ．Pm ， MAR and BFR／T V in OVX rats ． · １ ３ ６ · Table 1 Effects of ESE on body weight ， uterine weight and BMD in OVX rats 12 weeks after administration Table 2 Effects of ESE on serum biochemical parameters in ovariectomized rats Table 3 Effects of ESE on static parameters of proximal tibial cancellous bone histomorphometry in ovariectomized rats Table 4 Effects of ESE on dynamic parameters of proximal tibial cancellous bone histomorphometry in ovariectomized rats
The present study clearly demonstrates the use fulness and beneficial effects of ESE in the preven tion of bone loss induced by ovariectomy ． It is well known that estrogen deficiency is an important risk factor in the pathogenesis of osteoporosis ． Ovariec tomy results in great decrease in uterine weight ， bone mineral density ， histomorphometric index ， and so on ． These changes are mostly due to estro gen deficiency ． Our data on body weight and serum alkaline phos phatase supported the observations of other investi gators that both gained body weight and elevated serum alkaline phosphatase due to ovarian hormone deficiency are prevented by estrogen administra tion ［ １ ３ ］ ． The present results showed that both ESE and １７βestradiol inhibited both OVXinduced gained body weight and elevated serum alkaline phospha tase ． It is well known that calcium ， phosphorus ， E２ ， and BGP are widely accepted phenotype markers of the bone formation ［ １ ４ ］ ． In this study ， treatment with ESE and １７βestradiol completely corrected the decreased concentrations of calcium ， · ２ ３ ６ · phosphorus ， E２ ， and BGP in serum observed in OVX rats ． The present data showed that OVX decreased the weight of uterus ， when compared with the sham operated group ．Administration of ESE significantly increased the uterine weight in ovariectomized rats ． These results suggested that ESE maybe pos sess of a characteristic of estrogen agonist ． It thus further supports our previous observation ． It is also suggested that ESE may have a similar effect as １７βestradiol on bone loss and uterine weight ． Our findings showed that OVX rats developed bone changes similar to those seen in estrogen deficient osteoporotic women ， most markedly a decrease in bone density ． ESE may significantly improve the bone density ． In the present study ， ESE is effective in preventing bone loss and estro gen deficiency for treatment of osteoporosis ． Histomorphometric examination of the proximal tibiae of ESE groups revealed that the protective action of the extract may be due to an increase in bone formation ［ １ ５ ］ ． In conclusion ， the results obtained in the present study provide evidences that ESE importantly con tributes to the prevention or treatment of the devel opment of bone loss induced by ovariectomy in rats ． The studies on the isolation and characterization of the active chemical constituents are in progress ．
